Quantinuum, a subsidiary of Honeywell (NYSE: HON), is a leader in trapped-ion quantum computing, offering the H1 and H2 systems. The company is uniquely positioned to capitalize on the growing demand for quantum solutions in cryptography, drug discovery, and optimization. Over the next 12 months, key catalysts include the launch of the next-generation H2 system, expanded partnerships with cloud providers like Microsoft Azure and Amazon Braket, and potential government contracts from the US and UK for quantum cybersecurity. Honeywell’s strong balance sheet (over $10 billion in cash and short-term investments) provides a safety net, while the quantum division is expected to achieve positive EBITDA by 2027. Risks include competition from superconducting qubit players like IBM and Google, and the nascent state of the quantum market. However, with a market cap of ~$130 billion, HON offers a diversified play on quantum without the volatility of pure-play stocks. Disclaimer: This is not financial advice. Investing involves risk, including loss of principal. Past performance does not guarantee future results.